17,196 Shares in Cencora, Inc. $COR Bought by Meiji Yasuda Asset Management Co Ltd.

Meiji Yasuda Asset Management Co Ltd. purchased a new position in Cencora, Inc. (NYSE:COR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 17,196 shares of the company’s stock, valued at approximately $4,866,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Te Ahumairangi Investment Management Ltd acquired a new position in shares of Cencora during the second quarter valued at about $2,142,000. Mission Financial Group LLC acquired a new stake in shares of Cencora in the 2nd quarter valued at about $396,000. Globeflex Capital L P bought a new stake in Cencora in the 2nd quarter valued at about $974,000. Haverford Trust Co bought a new stake in Cencora in the 2nd quarter valued at about $241,000. Finally, Clear Harbor Asset Management LLC acquired a new position in Cencora during the 2nd quarter worth approximately $1,494,000. 97.52% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on COR. Wall Street Zen upgraded Cencora from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Citigroup restated a “buy” rating on shares of Cencora in a report on Thursday, August 6th. Wells Fargo & Company upped their target price on Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. increased their target price on Cencora from $382.00 to $390.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. Finally, Barclays reduced their price target on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a research report on Wednesday, June 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Cencora currently has an average rating of “Moderate Buy” and a consensus price target of $370.85.

Cencora Price Performance

Shares of NYSE COR opened at $317.89 on Monday. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The stock has a market cap of $60.66 billion, a price-to-earnings ratio of 23.62, a PEG ratio of 1.83 and a beta of 0.57. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93. The firm’s 50-day simple moving average is $302.59 and its 200 day simple moving average is $311.52.

Cencora (NYSE:COR) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 EPS for the quarter, topping analysts’ consensus estimates of $4.35 by $0.13. The firm had revenue of $84.75 billion during the quarter, compared to analyst estimates of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The company’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the previous year, the company posted $4.00 EPS. As a group, research analysts anticipate that Cencora, Inc. will post 17.87 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a dividend of $0.60 per share. The ex-dividend date is Friday, August 14th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio is 17.83%.

Cencora announced that its board has initiated a stock buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in shares. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Insider Transactions at Cencora

In related news, Director Lauren M. Tyler purchased 550 shares of the stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, with a total value of $148,626.50. Following the transaction, the director owned 4,359 shares of the company’s stock, valued at $1,177,932.57. This represents a 14.44% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.38% of the company’s stock.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.